Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells.

Wang LH, Pfister TD, Parchment RE, Kummar S, Rubinstein L, Evrard YA, Gutierrez ME, Murgo AJ, Tomaszewski JE, Doroshow JH, Kinders RJ.

Clin Cancer Res. 2010 Feb 1;16(3):1073-84. doi: 10.1158/1078-0432.CCR-09-2799. Epub 2010 Jan 26.

PMID:
20103672
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials.

Devriese LA, Voest EE, Beijnen JH, Schellens JH.

Cancer Treat Rev. 2011 Dec;37(8):579-89. doi: 10.1016/j.ctrv.2011.04.006. Epub 2011 May 17. Review.

PMID:
21592671
[PubMed - indexed for MEDLINE]
3.
4.

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.

Hou JM, Greystoke A, Lancashire L, Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A, Ranson M, Lorigan P, Dive C, Blackhall FH.

Am J Pathol. 2009 Aug;175(2):808-16. doi: 10.2353/ajpath.2009.090078. Epub 2009 Jul 23.

PMID:
19628770
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Use of γH2AX and other biomarkers of double-strand breaks during radiotherapy.

Sak A, Stuschke M.

Semin Radiat Oncol. 2010 Oct;20(4):223-31. doi: 10.1016/j.semradonc.2010.05.004. Review.

PMID:
20832014
[PubMed - indexed for MEDLINE]
6.

Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.

Tokudome N, Ito Y, Takahashi S, Kobayashi K, Taira S, Tsutsumi C, Oto M, Oba M, Inoue K, Kuwayama A, Masumura K, Nakayama Y, Watanabe C, Hatake K.

Breast Cancer. 2011 Jul;18(3):195-202. doi: 10.1007/s12282-011-0259-4. Epub 2011 Apr 5.

PMID:
21465230
[PubMed - indexed for MEDLINE]
7.

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

Schwarzenbach H, Alix-Panabières C, Müller I, Letang N, Vendrell JP, Rebillard X, Pantel K.

Clin Cancer Res. 2009 Feb 1;15(3):1032-8. doi: 10.1158/1078-0432.CCR-08-1910.

PMID:
19188176
[PubMed - indexed for MEDLINE]
Free Article
8.

Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.

Goodman OB Jr, Symanowski JT, Loudyi A, Fink LM, Ward DC, Vogelzang NJ.

Clin Genitourin Cancer. 2011 Sep;9(1):31-8. doi: 10.1016/j.clgc.2011.04.001. Epub 2011 Jun 25.

PMID:
21705286
[PubMed - indexed for MEDLINE]
9.

TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.

Yoon SO, Kim YT, Jung KC, Jeon YK, Kim BH, Kim CW.

Lung Cancer. 2011 Feb;71(2):209-16. doi: 10.1016/j.lungcan.2010.04.017. Epub 2010 May 14.

PMID:
20471712
[PubMed - indexed for MEDLINE]
10.

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW.

Clin Cancer Res. 2011 Jun 1;17(11):3600-18. doi: 10.1158/1078-0432.CCR-11-0255. Epub 2011 Apr 19.

PMID:
21505063
[PubMed - indexed for MEDLINE]
Free Article
11.

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.

Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, Kontopodis E, Hatzidaki D, Mavroudis D, Georgoulias V.

Br J Cancer. 2009 Aug 18;101(4):589-97. doi: 10.1038/sj.bjc.6605183. Epub 2009 Jul 21.

PMID:
19623181
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.

Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT.

Clin Cancer Res. 2009 Feb 1;15(3):1005-12. doi: 10.1158/1078-0432.CCR-08-1515.

PMID:
19188172
[PubMed - indexed for MEDLINE]
Free Article
13.

Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.

Bonmassar L, Fossile E, Scoppola A, Graziani G, Prete SP, Formica V, Cappelletti D, De Vecchis L, Cardillo A, Concolino F, D'Atri S, Balduzzi A, Torino F, Caporaso P, Greiner JW, Bonmassar E, Roselli M, Aquino A.

Anticancer Res. 2010 Nov;30(11):4721-30.

PMID:
21115931
[PubMed - indexed for MEDLINE]
14.

Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.

Liebes L, Potmesil M, Kim T, Pease D, Buckley M, Fry D, Cho J, Adler H, Dar K, Zeleniuch-Jacquotte A, Hochster H.

Clin Cancer Res. 1998 Mar;4(3):545-57.

PMID:
9533521
[PubMed - indexed for MEDLINE]
Free Article
15.

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Mostert B, Kraan J, Bolt-de Vries J, van der Spoel P, Sieuwerts AM, Schutte M, Timmermans AM, Foekens R, Martens JW, Gratama JW, Foekens JA, Sleijfer S.

Breast Cancer Res Treat. 2011 May;127(1):33-41. doi: 10.1007/s10549-010-0879-y. Epub 2010 Apr 9.

PMID:
20379845
[PubMed - indexed for MEDLINE]
16.

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.

Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C.

Acta Oncol. 2011 Jun;50(5):700-10. doi: 10.3109/0284186X.2010.549151. Epub 2011 Jan 24.

PMID:
21261508
[PubMed - indexed for MEDLINE]
17.

Can γH2AX be used to personalise cancer treatment?

Shah K, Cornelissen B, Kiltie AE, Vallis KA.

Curr Mol Med. 2013 Dec;13(10):1591-602. Review.

PMID:
24206133
[PubMed - indexed for MEDLINE]
18.

Using circulating tumor cells as a prognostic indicator in metastatic castration-resistant prostate cancer.

Delacruz A.

Clin J Oncol Nurs. 2012 Apr;16(2):E44-7. doi: 10.1188/12.CJON.E44-E47. Review.

PMID:
22459536
[PubMed - indexed for MEDLINE]
19.

Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.

Fan T, Zhao Q, Chen JJ, Chen WT, Pearl ML.

Gynecol Oncol. 2009 Jan;112(1):185-91. doi: 10.1016/j.ygyno.2008.09.021. Epub 2008 Oct 26.

PMID:
18954898
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Potential applications for circulating tumor cells expressing the insulin-like growth factor-I receptor.

de Bono JS, Attard G, Adjei A, Pollak MN, Fong PC, Haluska P, Roberts L, Melvin C, Repollet M, Chianese D, Connely M, Terstappen LW, Gualberto A.

Clin Cancer Res. 2007 Jun 15;13(12):3611-6.

PMID:
17575225
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk